CDK4 and neoplasm: For example, CDK4/6 inhibition was shown to enhance antigen presentation, which accompanied an increased IFNγ response; interestingly, the authors linked this outcome with downregulation of DNMT1, hypomethylation of TEs, and enhanced chemokine secretion that stimulated tumor immune surveillance5.